Furthermore, in the tumor microenvironment of high-risk LUAD patients, although the abundance of CTLs and pro-inflammatory immune signals increases, the functions of these immune cells may be constrained by MUC16-mediated immunosuppression (211, 214, 215). This evidence concerns the gene MUC16 and neoplasm.